Skip Navigation



JAC Advance Access published online on June 24, 2008
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkn258
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
62/2/217    most recent
dkn258v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Leibovici, L.
Right arrow Articles by Johnson, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leibovici, L.
Right arrow Articles by Johnson, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Editorial

Randomized controlled trials in the Journal of Antimicrobial Chemotherapy

Leonard Leibovici1,2,*, Colin Drummond3 and Alan Johnson3

1 Department of Medicine E, Rabin Medical Center, Beilinson Campus, 49100 Petah-Tiqva, Israel 2 Sackler Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel Aviv, Israel 3 JAC Editorial Office, Griffin House, 53 Regent Place, Birmingham B1 3NJ, UK

* Corresponding author. Tel: +972-3937-6501; Fax: +972-3937-6512; E-mail: leibovic{at}post.tau.ac.il

Abstract

The Journal of Antimicrobial Chemotherapy welcomes submissions of well-reported randomized controlled trials (RCTs) with solid methodology based on the CONSORT statement (http://www.consort-statement.org). The Journal would be especially happy to publish RCTs in the area of antimicrobial chemotherapy if they address significant problems and look at measurable outcomes that matter to patients.

Key Words: evidence-based medicine , clinical outcomes


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.